Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viveve Medical Inc
(NQ:
VIVE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.2150 (10)
Ask (Size)
0.2193 (79)
Prev. Close
0.2201
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
10,723,857
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 18, 2023
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Via
InvestorPlace
Performance
More News
Read More
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 17, 2023
Via
Benzinga
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
January 17, 2023
Via
Benzinga
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
December 15, 2022
Via
ACCESSWIRE
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
December 01, 2022
Via
ACCESSWIRE
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 17, 2023
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
Via
Benzinga
Why Is Tritium (DCFC) Stock Up 27% Today?
January 17, 2023
Via
InvestorPlace
XPEV Stock Alert: What to Know as Xpeng Slashes Prices
January 17, 2023
Via
InvestorPlace
Why Is Mullen Automotive (MULN) Stock Down 11% Today?
January 17, 2023
Via
InvestorPlace
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
January 17, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 17, 2023
Via
InvestorPlace
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
January 17, 2023
Via
ACCESSWIRE
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
November 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
Via
Benzinga
InvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update
November 11, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
